Definitive Contract W58P0522C0017

This is a definitive contract awarded by the Joint Program Executive Office for Chemical and Biological Defense, a Defense Department agency, to Moderna, Inc. for 100 million doses of the SARS-CoV-2 mRNA-1273 vaccine. The $8.2 billion firm fixed price contract has an ultimate completion date of August 10, 2023. Moderna, a manufacturer of pharmaceutical goods, has previously received prime and subcontract awards from various government agencies including the Department of Veterans Affairs,...

This is a $1,754,345,480.45 definitive cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Moderna, Inc. for the development of an mRNA vaccine to licensure for the prevention of COVID-19. The contract includes pre-award costs, development of the mRNA vaccine to Biologics License Application (BLA), and domestic manufacturing scale-out. This award does not have a set-aside designation. Moderna, a for-profit pharmaceutical...

<p>The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (DOD - Army - USASC) awarded an $8.66 billion definitive contract to Pfizer Inc., doing business as Pfizer, for COVID-19 Adult MDV Vaccine. The contract is a firm fixed price agreement with a place of performance in New York, NY. The period of performance spans from June 29, 2022 through February 29, 2024. No subcontractors were identified.</p>

This federal contract award, valued at $1,908.33, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA), with an ultimate completion date of November 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...

This federal contract award, valued at $15,189.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 0.25 mL doses of the Moderna COVID-19 vaccine for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of November 27, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...

This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,302.54 firm fixed-price delivery order is for the procurement of Moderna COVID-19 vaccine doses (0.25 mL) for the 6-month to 11-year age group under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999...

This is a $3,037.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA) in 0.25 mL doses. The contract is not designated as a set-aside and represents a single delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC)...

This federal contract award, with ID SPE2DB20D3104|SPE2DB24FV3Z5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $45,567.60 fixed-price delivery order is for the procurement of 0.25 mL doses of the Moderna COVID-19 vaccine for ages 6 months to 11 years, under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of December 20, 2023. Amerisourcebergen Drug Corp holds a...

This federal contract award is for the delivery of 0.25 mL doses of the Moderna COVID-19 vaccine for the 6-month to 11-year age group under the Emergency Use Authorization (EUA). The $1,290.00 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 30, 2024 and does not have a set-aside designation, indicating...

This contract award, valued at $4,556.76, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Firm Fixed Price Delivery Order for the supply of MODERNA COVID 23-24 (6M-11Y) emergency use authorization (EUA) vaccine doses at $0.25 per dose. The award has an ultimate completion date of November 20, 2023. Amerisourcebergen is a major pharmaceutical distribution company that holds several Indefinite Delivery Contracts (IDCs)...